Skip to main content
Walvax Biotechnology Co.,Ltd. logo

Walvax Biotechnology Co.,Ltd. — Investor Relations & Filings

Ticker · 300142 ISIN · CNE100000WN2 LEI · 300300H82R2DIQXA8N24 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,790 across all filing types
Latest filing 2025-04-11 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 300142

About Walvax Biotechnology Co.,Ltd.

https://www.walvax.com

Walvax Biotechnology Co.,Ltd. is a biopharmaceutical enterprise specializing in the research, development, production, and distribution of vaccines and other biological products. The company focuses on modern biotechnology to address public health challenges through a diverse portfolio of preventive vaccines. Key products include the 13-valent pneumococcal polysaccharide conjugate vaccine (PCV13), the bivalent human papillomavirus (HPV) vaccine, and various combination vaccines for meningitis and Haemophilus influenzae type b (Hib). Walvax operates advanced R&D platforms and manufacturing facilities that comply with international quality standards. The company is actively involved in the development of next-generation vaccine technologies, including mRNA and recombinant protein platforms, aiming to provide affordable and high-quality immunization solutions for global markets.

Recent filings

Filing Released Lang Actions
2024年度内部控制评价报告
Audit Report / Information Classification · 95% confidence The document is titled '2024 年度内部控制评价报告' which translates to '2024 Annual Internal Control Evaluation Report' for Yunnan Watson Biotechnology Co., Ltd. It discusses the company's internal control evaluation, including the scope, methodology, and conclusions about the effectiveness of internal controls as of December 31, 2024. The content includes detailed descriptions of internal control systems, governance, risk management, compliance with laws and regulations, and operational effectiveness. This type of report is a standalone audit-related document focusing on internal control evaluation rather than a full annual report or financial statements. It does not appear to be an announcement or a brief summary but a comprehensive internal control evaluation report. Therefore, it fits best under the category 'Audit Report / Information (AR)', which covers standalone audit reports and internal control evaluations. FY 2024
2025-04-11 Chinese
2024 Sustainability Report
Annual Report Classification · 95% confidence The document is a comprehensive report from Walvax Biotechnology covering various aspects such as a message from the chairman, company profile, product overview, sustainable development management, corporate governance, environmental management, and key figures for the year 2024. It includes detailed narrative on business strategy, R&D investment, product approvals, and sustainability initiatives. The length is substantial (15,000 characters) and contains substantive content rather than just an announcement or summary. There is no indication that this is a short announcement or a certification letter. The content aligns with a full annual report covering company activity and performance over the fiscal year 2024. Therefore, the document fits the definition of an Annual Report (10-K). FY 2024
2025-04-11 Chinese
募集资金存放与实际使用情况审核报告
Audit Report / Information Classification · 95% confidence The document is titled as an audit report on the use and storage of raised funds by Yunnan Watson Biotechnology Co., Ltd. It is issued by a certified public accounting firm and includes detailed financial data on the raised funds, their management, usage, and compliance with regulatory requirements for the year 2024. The document contains an auditor's opinion, references to regulatory guidelines, and extensive financial tables and explanations about the raised funds. It is not a full annual report but a specialized audit report focusing on the raised funds' storage and actual usage. This matches the definition of an Audit Report / Information (AR) filing, which includes standalone audit reports and applied accounting principles related to specific financial matters, excluding full annual reports. The document length (15,000 characters) and content confirm it is the report itself, not just an announcement or certification. Therefore, the correct classification is AR with high confidence. FY 2024
2025-04-11 Chinese
2024年度可持续发展报告
Regulatory Filings
2025-04-11 Chinese
2024年年度报告披露提示性公告
Report Publication Announcement Classification · 100% confidence The document is a short announcement (416 characters) indicating that the company's 2024 Annual Report and its summary have been approved and published on a regulatory website. It does not contain the actual annual report or financial data but rather informs investors about the availability of the report. According to the 'MENU VS MEAL' rule, such a brief notice about report publication should be classified as a Report Publication Announcement (RPA), not as the Annual Report (10-K) itself.
2025-04-11 Chinese
监事会决议公告
Audit Report / Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 19th meeting of the 5th Supervisory Board of Yunnan Watson Biotechnology Co., Ltd. It includes approvals of the 2024 Annual Report, 2024 Audited Financial Report, 2024 Financial Budget Report, Internal Control Evaluation Report, and other related reports. The document states that these reports are available on the designated disclosure website (巨潮资讯网), indicating this document itself is not the full annual report but a supervisory board meeting resolution announcement. The document is over 5,000 characters and contains substantive content about the supervisory board's review and approval of the annual report and related financial documents, which aligns with the nature of an Audit Report / Information filing rather than a simple announcement or a full Annual Report. It is not a certification letter or a brief announcement but a formal supervisory board resolution document reviewing and approving the annual financial reports and related matters. Therefore, the best fitting category is Audit Report / Information (AR). FY 2024
2025-04-11 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.